JUL 13, 2020 9:35 AM PDT

Russia Completes First Human Trial for COVID-19 Vaccine

WRITTEN BY: Annie Lennon

The Sechenov University Center for Clinical Research in Moscow, Russia, has completed its first round of clinical trials for a COVID-19 vaccine candidate. This makes it the first COVID-19 vaccine in the world to have completed human trials. 

In June, Russia approved two clinical for different formulations of a COVID-19 vaccine candidate. One was an intramuscular solution to be tested at the Burdenko Military Hospital. The other was a powdered form to be tested in Sechenov University. The approvals came after trials investigating the vaccines’ toxicity, safety, immunogenicity, and effectiveness in animal models.

Rather than seeing whether the vaccine may effectively prevent COVID-19, Alexander Lukashev, Director of the Institute of Medical Parasitology, Tropical, and Vector-borne Diseases at Sechenov University, said that the objective of this study was to establish the safety of the vaccine for humans. And according to their results, they believe that it is safe. 

The vaccine used by the researchers is a recombinant adenovirus vaccine. This means that, instead of injecting people with weakened or inactive forms of the coronavirus, they used synthetic agents that mimic their properties to induce an immuno-response capable of wiping out the real virus. 

During the study, the participants were kept in isolation with limited contact to the outside world from before tests started to ensure they were not already infected. The first round of testing commenced on June 18th on 18 participants, while the second round happened on 20 volunteers on June 23rd. 

After being given the vaccine, they were to remain in quarantine in the hospital for 28 days. Once released later this month, the volunteers will be further monitored to evaluate their immunity. 

Although promising results, no information on when the vaccine will reach commercialization has been released. More data is also still needed on how effective the vaccine is at preventing infection by the virus. 

 

Sources: LentaRussia TodayForbes

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUL 17, 2020
Cancer
Tackling the Problem of Toxicity in Breast Cancer Therapy
JUL 17, 2020
Tackling the Problem of Toxicity in Breast Cancer Therapy
Chemotherapy has been one of the primary methods of cancer treatment for decades. Usually, a doctor applies a chemothera ...
AUG 06, 2020
Immunology
Resetting the Body's Danger Sensor
AUG 06, 2020
Resetting the Body's Danger Sensor
The human body has a sophisticated danger-sensing mechanism that alerts the immune system when something is not right. T ...
AUG 11, 2020
Drug Discovery & Development
FDA Approves New Opioid for Short-Term Use
AUG 11, 2020
FDA Approves New Opioid for Short-Term Use
The US Food and Drug Administration has announced the approval of Olinvyk (oliceridine), a new opioid that can help mana ...
AUG 16, 2020
Cannabis Sciences
Cannabinoids May Interact with Prescribed Medications
AUG 16, 2020
Cannabinoids May Interact with Prescribed Medications
Despite the growing popularity of cannabis products, information is currently limited on how they may interact with othe ...
AUG 25, 2020
Cannabis Sciences
Synthetic Cannabinoid Drug to Enter Human Trials
AUG 25, 2020
Synthetic Cannabinoid Drug to Enter Human Trials
In recent months, interest has been growing in the potential for cannabinoids- the compounds found in cannabis- to treat ...
SEP 04, 2020
Drug Discovery & Development
Fecal Transplant Successfully Treats Alcoholism
SEP 04, 2020
Fecal Transplant Successfully Treats Alcoholism
Researchers from Virginia Commonwealth University have found that fecal transplants can reduce drinking behaviors in peo ...
Loading Comments...